Daniel Beswick-Canizalez is a PhD Researcher at GSK and the University of Strathclyde, focusing on antibody drug conjugates. Colleagues describe them as "It is always a privilege to work alongside Daniel. Daniel possesses a remarkable strategic mind, complemented by a creative and efficient approach to tackling complex problems. His ability to grasp and adeptly apply abstract concepts sets him apart in a way that's truly rare. Daniel is a highly valuable asset to any team lucky enough to have him as a member."